Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H2S-synthesizing pathways by Prieto-Lloret, Jesus et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1113/jphysiol.2014.277046
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Prieto-Lloret, J., Shaifta, Y., Ward, J., & Aaronson, P. (2015). Hypoxic pulmonary vasoconstriction in isolated rat
pulmonary arteries is not inhibited by antagonists of H2S-synthesizing pathways. The Journal of Physiology,
593(2), 385-401. https://doi.org/10.1113/jphysiol.2014.277046
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
J Physiol 593.2 (2015) pp 385–401 385
Th
e
Jo
u
rn
al
o
f
Ph
ys
io
lo
g
y
Hypoxic pulmonary vasoconstriction in isolated rat
pulmonary arteries is not inhibited by antagonists of
H2S-synthesizing pathways
Jesus Prieto-Lloret, Yasin Shaifta, Jeremy P. T. Ward and Philip I. Aaronson
Division of Asthma, Allergy & Lung Biology, School of Medicine, King’s College London, London WC2R 2LS, UK
Key points
 We evaluated the hypothesis that an increase in the hydrogen sulphide concentration in
pulmonary artery smooth muscle cells (PASMCs) causes hypoxic pulmonary vasoconstriction
(HPV) by examining the effects of the sulphide donor cysteine and sulphide-synthesis blockers
on HPV in isolated rat intrapulmonary arteries (IPAs).
 Cysteine (1 mM) enhanced HPV and also the contraction to prostaglandin F2α (PGF2α) and
both effects were abolished by the cystathionine γ-lyase (CSE) blocker propargylglycine (PAG,
1 mM), which had little or no non-selective effect on contraction at this concentration.
 Neither PAG nor the cysteine aminotransferase (CAT) antagonist aspartate affected HPV in
normal physiological saline solution (PSS), or in PSS containing physiological concentrations
of cysteine, cystine and glutamate, whereas dithiothreitol (DTT), proposed to enhance HPV
by converting mitochondrial thiosulphate to sulphide, instead abolished HPV.
 PAGmarkedly diminished whereas DTT did not affect cysteine-induced sulphide release from
liver pieces.
 The results do not support the proposal that hydrogen sulphide plays a role in HPV.
Abstract An increase in the H2S (hydrogen sulphide, hereafter sulphide) concentration in
pulmonary artery smooth muscle cells (PASMCs) has been proposed to mediate hypoxic
pulmonary vasoconstriction (HPV). We evaluated this hypothesis in isolated rat intrapulmonary
arteries (IPAs) by examining the effects of the sulphide precursor cysteine and sulphide-synthesis
blockers on HPV and also on normoxic pulmonary vasoconstriction (NPV) stimulated by
prostaglandin F2α (PGF2α) and by the drug LY83583, which causes contraction in IPAs
by increasing cellular reactive oxygen species levels. Experiments with several blockers of
cystathionine γ-lyase (CSE), the enzyme responsible for sulphide synthesis in the vasculature,
demonstrated that propargylglycine (PAG, 1 mM) had little or no effect on the NPV caused
by PGF2α or LY83583. Conversely, other CSE antagonists tested, aminooxyacetic acid (AOAA,
100 μM), β-cyanoalanine (BCA, 500 μM) and hydroxylamine (HA, 100 μM), altered the NPV
to PGF2α (BCA increased, HA inhibited) and/or LY83583 (BCA increased, AOAA and HA
inhibited). Preincubating IPAs in physiological saline solution (PSS) containing 1 mM cysteine
increased the amplitude of the NPV to PGF2α by 50%, and had a similar effect on HPV
elicited by hypoxic challenge with 0% O2. The enhancement of both responses by cysteine was
abolished by pretreatment with 1 mM PAG. Measurements carried out with an amperometric
electrode demonstrated that incubation with 1 mM cysteine under anoxic conditions (to
minimize sulphide oxidation) greatly potentiated the release of sulphide from pieces of rat liver
and that this release was strongly antagonized by PAG, indicating that at this concentration
PAG could enter cells intact and antagonize CSE. PAG at 1 mM had no effect on HPV recorded
in control PSS, or in PSS supplemented with physiological concentrations of cysteine (10 μM),
cystine (50μM) and glutamate (100μM) in order to prevent the possible depletion of intracellular
cysteine during experiments. Application of a combination of 1 mM cysteine and 1 mM
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α-ketoglutarate to promote sulphide synthesis via the cysteine aminotransferase/
mercaptopyruvate sulphurtransferase (CAT/MST) pathway caused an increase in HPV
similar to that observed for cysteine. This was partially blocked by the CAT antagonist aspartate
(1 mM) and also by PAG. However, HPV was not increased by 1 mM α-ketoglutarate alone,
and HPV in the absence of α-ketoglutarate and cysteine was not attenuated by aspartate.
Pretreatment of IPAs with dithiothreitol (DTT, 1 mM), proposed to promote the conversion of
mitochondrial thiosulphate to sulphide, did not increase the release of sulphide from pieces of
rat liver in either the presence or the absence of 1 mM cysteine, and virtually abolished HPV.
The results provide evidence that the sulphide precursor cysteine can promote both NPV and
HPV in rat IPA by generating sulphide via a PAG-sensitive pathway, presumably CSE. However,
HPV evoked under control conditions was unaffected by the blockade of CSE. Moreover, HPV
was not affected by the CAT antagonist aspartate and was blocked rather than enhanced by DTT.
The data therefore indicate that sulphide generated by CSE or CAT/MST or from thiosulphate
is unlikely to contribute to O2 sensing during HPV in these arteries.
(Received 12 May 2014; accepted after revision 31 October 2014; first published online 6 November 2014)
Corresponding author P. I. Aaronson: Room 1.19, Henriette Raphael House, Guy’s Campus, King’s College London,
London SE1 9HN, UK. Email: philip.aaronson@kcl.ac.uk
Abbreviations AOAA, aminooxyacetic acid; BCA,β-cyanoalanine; CAT, cysteine aminotransferase; CBS, cystathionine
β-synthase; CSE, cystathionine γ-lyase; DHLA, dihydrolipoic acid; DTT, dithiothreitol; HA, hydroxylamine; HPV,
hypoxic pulmonary vasoconstriction; IPA, intrapulmonary artery; MST, mercaptopyruvate sulphurtransferase; NPV,
normoxic pulmonary vasoconstriction; PA, pulmonary artery; PAG, propargylglycine; PASMC, pulmonary artery
smooth muscle cell; PGF2α, prostaglandin F2α; PSS, physiological saline solution; ROS, reactive oxygen species.
Introduction
Hydrogen sulphide (H2S, hereafter sulphide) has recently
emerged as a biologically active gas with multiple effects
on the cardiovascular system. Although these are not as
well understood as those of nitric oxide (NO), it appears
that the two gases generally cause similar responses with
regard to vasodilatation, cardioprotection, angiogenesis
and inhibition of smoothmuscle cell proliferation (Wang,
2011). There seem to be multiple mechanisms by which
sulphide can potentially cause vasodilation, including
hyperpolarization of endothelial and/or vascular smooth
muscle cells through activation of several types of K+
channels; inhibition of cGMP phosphodiesterasemay also
make a contribution (Wang, 2011).
Sulphide, however, differs from NO in that it can cause
vasoconstriction in some systemic arteries, notably those
from non-mammalian species such as duck, alligator
and lamprey (Dombkowski et al. 2005; Olson et al.
2006). Sulphide also constricts bovine pulmonary arteries
(PAs), and causes a complex triphasic response in
pre-constricted rat PAs consisting of a small transient
contraction followedby relaxation and then a secondmore
sustained constriction. In both arteries, the response to
sulphide resembled theprofileofhypoxicpulmonaryvaso-
constriction (HPV), the constricting response evoked by
hypoxia (Olson et al. 2006;Aaronson et al. 2012). Likewise,
hypoxia and sulphide show a remarkable similarity in
their constricting or relaxing effects on various arteries
from a wide range of mammalian (e.g. cow, sea lion) and
non-mammalian (e.g. hagfish, shark, toad, trout) species
(Olson et al. 2006; Olson &Whitfield, 2010).
These findings prompted the proposal (Olson et al.
2006, 2010) that sulphide is the universal mediator of both
hypoxic constriction and hypoxic vasodilation. This idea
is also supported by observations that levels of sulphide
produced by rat PAs (Madden et al. 2012) and lung homo-
genate (Olson & Whitfield, 2010) increased under anoxic
conditions and fell in the presence of oxygen, an effect
consistent with the concept that hypoxia increases cellular
[sulphide] by attenuating its metabolism, which involves
oxidation to sulphite and sulphate. In addition, incubation
of bovine PAs in the sulphide precursor cysteine
increased the amplitude of HPV, with an even more
marked enhancement observed when arteries were treated
with a combination of cysteine and α-ketoglutarate,
which would favour the production of sulphide via
cysteine aminotransferase (CAT) and mercaptopyruvate
sulphurtransferase (MST) (Olson et al. 2010). Crucially,
HPV was also seen to be blocked by antagonists
of the enzymes which metabolize cysteine and other
thiol-containing amino acids to produce sulphide (Olson
et al. 2006, 2010; Madden et al. 2012). These antagonists
include propargylglycine (PAG) and β-cyano-L-alanine
(BCA), claimed to be selective inhibitors of cystathionine
γ-lyase, and hydroxylamine (HA) and aminooxyacetic
acid (AOAA), which have been used as blockers
of cystathionine β-synthase (CBS) although recent
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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work indicates that BCA, HA and AOAA block both
cystathionine γ-lyase (CSE) and CBS whereas PAG is
selective for CSE (Asimakopoulou et al. 2013). Olson et al.
(2013) have also shown that HPV is enhanced by the
reducing agents dithiothreitol (DTT) and dihydrolipoic
acid (DHLA), both of which also increased sulphide
production by tissues supplemented with thiosulphide.
Based on this evidence, they proposed that reduction
of the mitochondrial redox state, which occurs during
hypoxia (Waypa et al. 2010), reduces mitochondrial
thiosulphate to sulphide, thereby contributing another
potentialmechanismbywhichhypoxiamight raise cellular
[sulphide].
Sulphide is also suggested to play an analogous role
in the carotid body, as evidenced by the inhibitory effect
of CSE knockout and PAG on O2 sensing in vivo and
in isolated glomus cells (Peng et al. 2010), although this
concept has been disputed (Buckler, 2012).
Although provocative, the proposal that sulphide acts
as an oxygen sensor in HPV remains to be verified
independently. The inhibitors of sulphide synthesis used to
study its involvement in HPV have been used at very high
concentrations (10 mM PAG, 1 mM AOAA, 10 mM BCA,
1 mM HA, 10 mM aspartate; Olson et al. 2006; Madden
et al. 2012), and the possibility that these drugs cause
non-specific effects on contraction at these concentrations
has not been carefully assessed. It is also the case that
the CSE/CBS blocker AOAA blocked HPV in bovine PAs
(Olson et al. 2006) and the more selective CSE inhibitor
PAG did not (Olson et al. 2006), whereas it was sub-
sequently shown that CSE but not CBS is expressed in
bovine pulmonary artery smooth muscle cells (PASMCs)
(Olson et al. 2010). In the present study, we therefore
examined the contractile effects of sulphide synthesis
inhibitors on HPV and also on contractions evoked
under normoxic conditions by the agonist prostaglandin
F2α (PGF2α) and the drug LY83583, which generates
reactive oxygen species (ROS) within cells, in rat intra-
pulmonary arteries (IPAs). We find that the sulphide
synthesis inhibitors BCA, AOAA and HA have marked
effects on contractions. PAG and aspartate, which lack
these non-selective effects on contraction, have no effect
on HPV.
Methods
Ethical approval
This study conforms with the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised
1996) and is in accordance with UK Home Office
regulations (Animals (Scientific Procedures) Act, 1986).
Male Wistar rats (200–300 g; 6–8 weeks old) were killed
by lethal injection (I.P.) of sodium thiopental.
IPA mounting and measurement of tension
development
The heart and lungs were excised and placed in
cold physiological salt solution (PSS), which contained
(mmol l−1): 118 NaCl, 24 NaHCO3, 1 MgSO4, 0.435
NaH2PO4, 5.56 glucose, 1.8 CaCl2 and 4 KCl. Rings of
IPA (inner diameter 0.5–1.0 mm) were dissected free of
adventitia andparenchymaunder adissectionmicroscope,
mounted on a conventional small vessel wire myograph,
and stretched to give a basal tension of 5–6mN(equivalent
to an internal pressure of 15 mmHg). They were then
equilibrated with three brief exposures to PSS containing
80 mmol l−1 KCl (80KPSS; isotonic replacement of NaCl
by KCl). Hypoxia was induced by switching from 95%
air/5% CO2 to either 0% O2/5% CO2/balance N2 or 2%
O2/5% CO2/balance N2. All experiments were conducted
at 37°C.
RT-PCR
RNAwas isolated fromhomogenates of freshly isolated rat
IPAs and reverse transcription carried out as previously
described (Knock et al. 2008). RT-PCR primer pairs were
designed using Primer3web version 4.0 (http://primer3.
ut.ee) and synthesized by Sigma-Aldrich (St Louis, MO,
USA). MPT (accession no. NM 138843): sense CCT-
TCATCAAGACCCACGAG, antisense TGGACAGGT-
CCACCTTCTTC; CβS (accession no. NM 012522):
sense ATGCTGCAGAAAGGCTTCAT, antisense CAACA-
CCAAACACCATCAG; CγL (accession no. NM 017074):
sense GGTTTTGTATACAGCCGCTCTGG, antisense
TGCAAATGACTTCATCTCCTGCT. PCR was carried out
using PuReTaq Ready-To-Go PCR Beads (GE Healthcare,
Piscataway, NJ, USA) and the PCR products (reaction
equivalent on 20 ng reverse transcribed RNA) were
analysed by electrophoresis on 2.8% agarose gels run
in TAE buffer (National Diagnostics, Hessle, UK) with
PhiX174 DNA/HinfI Marker (Thermoscientific Inc.,
Waltham, MA, USA).
Measurement of sulphide
The sulphide concentration was measured and recorded
using an amperometric sensor and an amplifier and
SensorTrace Basic software from Unisense A/S (Aarhus,
Denmark). Pieces of liver tissue weighing 175 mg were
pre-incubated in normal Krebs solution (previously
equilibrated with anoxic gas 5% CO2/N2) for 20 min
in a sealed vial. L-cysteine (1 mM) and/or DTT (3 mM)
were then added, and the sulphide concentration was
recorded for 30 min. To check if the magnitude of the
response to cysteine was affected by L-PAG the tissue
was pre-incubated in 1 mM L-PAG for 30 min before
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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starting the recording. Tissues from the same animal were
always paired for control recording (L-cysteine or DTT)
or treatment (L-PAG on L-cysteine or DTT responses).
Drugs and chemicals
PGF2α was from Enzo Life Sciences (Exeter, UK),
BCA was from VWR International (Radnor, PA, USA),
hydroxylamine was from MP Biomedicals (Santa Ana,
CA, USA), L-propargylglycine was from Santa Cruz
(Santa Cruz, CA, USA), α-ketoglutarate was from Fisher
Scientific (Loughborough, UK), and D,L-propargylglycine
and all other drugs were from Sigma-Aldrich (St Louis,
MO, USA). All drug stock solutions were made up in
distilled water, except for cystine which was dissolved in
1 M HCI and aspartate which was dissolved in 0.5M HCl.
At their final concentrations used for experiments, none of
the drugs used had an effect on pH, which wasmaintained
at 7.4.
HPV experimental protocol, data representation and
statistical analysis
IPAs were exposed to hypoxia for three periods, each
separated by 30 min. The duration of each hypoxic
episode was 45 min when the arteries were challenged
with 0% O2 and 20 min when 2% O2 was used; the
shorter period was used in the latter case to mini-
mize rundown of the response. The O2 concentration
in the myograph chambers, measured using a NeoFox
oxygen sensing system with a AL300 sensor (Ocean
Optics, Dunedin, FL, USA) fell within several minutes
to steady-state values of 6–9 mmHg when gassing with
0% O2 and 22–25 mmHg when gassing with 2% O2.
Tension was measured immediately before the imposition
of hypoxia, every 5 min during the hypoxic periods and
then 5 min after re-oxygenation, at which point HPV had
largely subsided.Hypoxia under these conditions typically
resulted in a rapid increase of force development within
1–3 min, which then plateaued, although in some tissues
the plateau was preceded by a small transient peak in
tension. Experiments were included for analysis if the
amplitude of the control HPV (measured at 45 min) was
 0.2 mN. To adjust for the slow progressive drift in the
baseline tension which occurred in some experiments,
an extrapolated line was drawn connecting the trend of
the baseline tension just before imposing hypoxia with the
trend of baseline tension following the exchange of the
solution after re-oxygenation. Where the baseline tension
after the solution exchange was clearly displaced away
from the trend, the line was instead extrapolated along
the trend of the baseline tension over5 min prior to the
imposition of hypoxia. The change in tension duringHPV
and after 5 min of re-oxygenation was then calculated as
the difference between the tension recorded at each time
point and thebaseline tensionvalues at that timeasdefined
by the line.
When 0% O2 is used for multiple successive hypoxic
challenges, the initial HPV differs in its shape from the
2nd and 3rdHPVs, which are indistinguishable (Connolly
et al. 2013). We therefore used the 2nd HPV as the control
response, and experimental interventions (e.g. application
of inhibitors or cysteine) were made 30 min prior to the
3rd hypoxic challenge. In some cases where we examined
the effect on HPV of a combination of two agents (e.g.
PAG and cysteine), the first was applied starting 30 min
before the 2nd hypoxic challenge and remained present
during the 3rd hypoxic challenge, whereas the second was
then applied after the 2nd HPV, starting 30 min before
the 3rd hypoxic challenge. For illustration of the results,
increases in tensionabovebaseline throughout the2ndand
3rd hypoxic challenges were expressed as a percentage of
the increase in force above baseline recorded at 45 min
of hypoxia during the 2nd (control) response. When
arteries were repeatedly challenged with 2% O2, the first
two HPVs were indistinguishable whereas the 3rd HPV
demonstrated some rundown, so in these experiments we
used the 1st and 2ndHPVs as the control and intervention
responses. The amplitudes of the control and intervention
HPVs were compared over 45 or 20 min using repeated
measures ANOVA followed by a Bonferroni post hoc test
to determine whether the intervention had significantly
changed the response.
A protocol similar to that used to record HPV in 0%
O2 was used to record the effects of sulphide donors and
synthesis inhibitors on themaximal normoxic pulmonary
vasoconstriction (NPV) to 30 μM PGF2α. Effects of
sulphide synthesis inhibitors on the NPV to 10 μM
LY83583were also examined. In this case, because repeated
responses to LY83583 were not always of consistent
amplitude, the inhibitor was applied once the contraction
elicited by a single application of LY83583 had reached a
stable level. Tension in the presence of LY83583 just before
the application of, and at the point of maximal response
to the sulphide synthesis inhibitor, was measured. These
results were analysed using Student’s paired t test. The
threshold for statistical significance for all comparisons
was set at P < 0.05. GraphPad Prism was used for all
analyses. Summary data values shown in the figures are
the mean ± SEM.
Results
Effects of sulphide synthesis inhibitors on NPV to
PGF2α and LY83583
In initial experiments carried out to determine
whether inhibitors of sulphide-synthesizing enzymes had
non-selective effects on contraction, we examined their
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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effects on the presumably sulphide-independent contra-
ctions of IPAs evoked under normoxic conditions by the
agonist PGF2α (30 μM) and the drug LY83583 (10 μM),
which causes constriction of IPAs by generating ROS
(Hasegawa et al. 2004; Knock et al. 2009).
As shown in Fig. 1A, neither AOAA (100 μM) nor
D,L-PAG (1 mM) had any effect on the NPV to 30 μM
PGF2α, whereas HA (100 μM) strongly inhibited and
BCA (500 μM) markedly potentiated the PGF2α response,
respectively. L-PAG (1 mM) caused a small but significant
potentiation. Figure 1B shows that D,L-PAG also had no
effect on the NPV evoked by LY83583, whereas L-PAG
caused a small further contraction; this was observed to
wane with time (data not shown). On the other hand,
the NPV to LY83583 was markedly inhibited by AOAA,
abolished by HA and strongly potentiated by BCA.
Cysteine enhances NPV to PGF2α and this effect is
blocked by sulphide synthesis inhibitors
Application of the sulphide precursor L-cysteine (1 mM),
although it seldom affected basal tone, consistently caused
a further increase in tensionwhen applied to IPAs that had
been preconstricted by PGF2α (Fig. 2A). This contraction
was concentration-dependent, with a threshold near 3μM
L-cysteine (Fig. 2B and C). Similarly, preincubation of
arteries for 30 min in 1 mM L-cysteine increased the NPV
to PGF2α by50% (Fig. 2D and Fig. 2E, leftmost bar).
In further experiments, we examined the effect of
the sulphide synthesis inhibitors on the enhancement by
L-cysteine of the NPV induced by 30μM PGF2α. IPAs were
incubated with the inhibitor for 30 min, and PGF2α was
applied. Immediately following washout of the agonist,
the inhibitor was re-applied together with 1 mM cysteine,
and after 30 min the artery was re-challenged with PGF2α.
As shown in Fig. 2E, each of the inhibitors markedly
inhibited or abolished the potentiation of the NPV caused
by cysteine, regardless of whether the inhibitor itself had
suppressed (HA), potentiated (BCA) or had little effect
(AOAA and PAG) on the PGF2α response.
As it appeared that, of the inhibitors tested, only PAG
was able to block the (presumably sulphide-dependent)
enhancement of the NPV caused by PGF2α with little
effect of its own on contraction, we also examined
whether PAGwas able to block sulphide synthesis in intact
tissue, and found that 1 mM L-PAG strongly suppressed
cysteine-induced sulphide production by rat liver (Fig. 3).
Therefore, only D,L-PAG and L-PAG were used to block
CSE in subsequent experiments.
Cysteine also causes an enhancement of HPV that is
blocked by PAG
As shown in Fig. 4A, the amplitude of HPV evoked by 0%
O2 was significantly increased by L-cysteine (1 mM), and
this was abolished by both D,L-PAG (Fig. 4B) and L-PAG
(Fig. 4C).
In contrast to the potentiation of HPV by cysteine,
the putative sulphide precursors GSH and homocysteine
had no effect on HPV (Fig. 5A and B), whereas GSSG
significantly attenuated HPV (Fig. 5C).
HPV is not blocked by PAG
Having shown that both L- and D,L-PAGwere able to block
cysteine-induced enhancement of bothHPV and the NPV
evokedbyPGF2α without appreciablenon-selective effects,
we used PAG to determine whether sulphide production
by CSE was required for HPV under more physiological
conditions. As shown in Fig. 6, preincubation with 1 mM
of either D,L-PAG or L-PAG had no effect on HPV evoked
by 0% O2 in normal PSS.
Toaddress thepossibility that the lackof effect ofPAGon
HPV arose because PAswere unable to synthesize sulphide
due to depletion of cysteine from the smooth muscle
and/or endothelial cells whichmight have occurred during
several hours of incubation in PSS, additional experiments
were carried out using PAs incubated in PSS supplemented
with 10μM cysteine, 50μM cystine and 100μM glutamate
to maintain cellular sulphide synthesis (see Discussion)
throughout the protocol. However, as illustrated in Fig. 7,
neither D,L-PAGnor L-PAGhad any effect onHPVs evoked
by either 0% O2 (Fig. 7A and B, respectively) or 2% O2
(Fig. 7D and E) in the ‘supplemented’ PSS. HPV elicited
by 2% O2 was stable with repeated hypoxic challenge in
the presence of the amino acids (Fig. 7C). Representative
traces of these experiments are shown in Fig. 7F.
Aspartate-sensitive enhancement of HPV by cysteine
and α-ketoglutarate
Incubation of IPA with the combination of L-cysteine and
α-ketoglutarate (both 1 mM) also increased the amplitude
of HPV. This effect appeared to be somewhat larger than
that caused by L-cysteine alone (Fig. 8A), although this
difference was not significant. We examined whether
the CAT/MST pathway of sulphide synthesis might be
operative in PAs under these conditions by using the
CAT antagonist aspartate, which competes with cysteine
for binding to the enzyme. As shown in Fig. 8B, 1 mM
aspartate markedly attenuated the increase in HPV caused
by the combination of L-cysteine and α-ketoglutarate. In
contrast, the blocking effect of aspartate was not observed
if only L-cysteine was used to enhance HPV (Fig. 8C;
the increase in HPV is not different from that shown
in Fig. 4A, P > 0.05). The enhancement of HPV by
L-cysteine and α-ketoglutarate was also diminished in the
presence of D,L-PAG (Fig. 8D), implying that under these
conditions sulphide synthesis by both CSE and CAT/MST
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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was contributing to the enhancement of HPV. Crucially,
however, application of α-ketoglutarate (1mM) on its own
hadnoeffect onHPVelicited innormalPSS (Fig. 9A), or in
PSS supplemented with 10μM cysteine, 50μM cystine and
100 μM glutamate so as to maintain intracellular cysteine
levels (Fig. 9B). Aspartate had no significant effect onHPV
in the absence of pretone (Fig. 9C), or on theNPVs elicited
by either 30 μM PGF2α or 10 μM LY83583 (Fig. 9D).
Effects of DTT on HPV and sulphide production by
liver
Olson et al. (2013) have recently shown that DTT
enhances HPV in rat PAs, interpreting this observation
as supporting the idea that hypoxia increases cellular
[sulphide] by reducing mitochondrial thiosulphate. In
contrast, we consistently observed that DTT (1 mM)
virtually abolished HPV, whether evoked by 0% O2 in
control PSS (Fig. 10A) or by 2% O2 in PSS supplemented
with cystine, cysteine and glutamate (Fig. 10B). Figure 10C
shows that 3 mM DTT had no effect on the production of
sulphide by liver samples, either under basal conditions
(left) or in the presence of 1mM cysteine to boost sulphide
production.
Expression of sulphide-synthesizing enzymes in rat
PAs
As shown in Fig. 11, mRNA for CSE and MST, but not
CBS, is expressed in rat IPAs.
Discussion
Olson et al. (2006) proposed that a reduction in the
ambient O2 concentration leads to an increase in cellular
[sulphide] in vascular smooth muscle cells, and that
this effect constitutes an O2 sensor that causes arterial
contraction or dilatation depending on vessel type. In PAs
this increase in cellular [sulphide] would trigger HPV.
They initially hypothesized that hypoxia would lead to
a rise in cellular [sulphide] by attenuating its oxidation,
but more recently have suggested that reduction of the
mitochondrial redox state, which has been shown to occur
during hypoxia (Waypa et al. 2010), could also raise
[sulphide] by promoting the conversion of mitochondrial
thiosulphate to sulphide (Olson et al. 2013). Enzymatic
pathways of sulphide synthesis andmetabolism relevant to
these proposals, as well as potential mechanisms by which
hypoxia might increase cellular sulphide and thereby
trigger HPV, are summarized in Fig. 12, which is largely
based on information presented in Go & Jones (2011),
Wang (2012) and Olson et al. (2013).
The proposal that sulphide is involved in HPV rests on
a number of observations. Exogenous NaHS and hypo-
xia are seen to cause similar constricting or dilatating
responses in a wide range of arteries from many species,
implying the existence of a ubiquitous causal relationship
between sulphide and hypoxia-induced changes in
vascular tone which arose early in evolution (Olson,
2012). In rat PAs, for example, application of NaHS
causes a complex tri-phasic response – a small transient
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Figure 1. Effect of sulphide synthesis blockers on the responses to PGF2α and LY83583
A, effect of several CSE antagonists (BCA, 500 μM; AOAA, 100 μM; HA, 100 μM; D,L-PAG, 1 mM; L-PAG, 1 mM)
on contractions evoked by 30 μM PGF2α . A control NPV to 30 μM PGF2α was recorded, the agonist was washed
out and the blocker was applied. PGF2α at 30 μM was then re-applied 30 min later. The percentage change in the
maximum amplitude of the second compared to the first PGF2α NPV is shown for each blocker. B, effect of several
PAG blockers on the contraction evoked by 10 μM LY83583. Blockers were added when the amplitude of the
LY83583-induced NPV reached a constant level, and the maximum change in tension from that level was recorded
and is plotted as the percentage of the LY83583 NPV immediately before addition of the blocker. ∗P < 0.05 vs.
control. The mean ± SEM NPVs to 30 μM PGF2α and 10 μM LY83583 were 3.05 ± 0.48 mN (n = 47) and
2.25 ± 0.26 mN (n = 30) in the absence of inhibitors, respectively.
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contraction followed by a relaxation and then a second
maintained contraction – the profile of which bears some
resemblance (albeit not a close one) to HPV (Olson et al.
2006). In addition, under anoxic conditions homogenates
of rat lung supplied with L-cysteine and α-ketoglutarate
produced sulphide, which was then consumed when O2
was introduced (Olson & Whitfield, 2010), and a similar
effect occurred in pieces of isolated rat small PA (Madden
et al. 2012). Also, HPV was greatly increased in iso-
lated bovine PAs in the presence of a range of sulphide
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Figure 2. Effects of L-cysteine on basal and PGF2α-induced tension in IPAs
A, example trace showing the increase in tension elicited by 1 mM L-cysteine during NPV induced by 5 μM PGF2α .
B, example of the concentration-dependent increase in tension evoked by cysteine (3 μM–3 mM) during an NPV
induced by 5 μM PGF2α . C, average increases in tension recorded using the protocol described for B shown as
percentage of the response to 80 mM K+ PSS, which represents the maximum contraction in that arterial ring
(n = 15). D, example of the effect of pre-treatment with 1 mM cysteine on the contraction evoked by 30 μM PGF2α .
E, mean ± SEM effect of 1 mM L-cysteine on the contraction evoked by 30 μM PGF2α in the absence (leftmost bar)
and presence of CSE inhibitors. ∗Significant effect (P < 0.05) of blocker on the response to cysteine alone. The
mean ± SEM NPV to 5 μM PGF2α was 1.58 ± 0.39 mN (n = 15) prior to the addition of cysteine.
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donors, including cysteine, cysteine+α-ketoglutarate and
glutathione (Olson et al. 2010), and in isolated perfused
rat lungs in the presence of α-ketoglutarate (Madden et al.
2012).
Nonetheless, the only direct evidence for a causal
relationship between sulphide and HPV is provided by
observations that HPV is blocked by several antagonists
of CSE and CBS, including PAG, AOAA, HA and BCA
(Olson et al. 2006, 2010), and also by aspartate (Madden
et al. 2012), which blocks CAT (Singh & Banerjee, 2011;
Whiteman et al. 2011). However, the concentrations of
the drugs which have been used to block CSE in studies
of HPV (PAG, 10 mM; HA, 1 mM; AOAA, 1 mM; BCA,
10 mM) are much higher than those which are required
to block purified CSE and CBS (Asimakopoulou et al.
2013). Results have also been variable, in that PAG did
not block HPV in isolated bovine PAs (Olson et al. 2006)
but abolished it in perfused rat lung (Madden et al. 2012).
More generally, the concentration-dependency ofCSE and
CBS inhibition by these drugs in intact cells is not well
understood, and all of them are known to have multiple
non-selective effects, although when used with the proper
controls they can provide meaningful information about
the role of sulphide in cellular function (Whiteman et al.
2011; Whiteman &Winyard, 2011).
Effects of cysteine and CSE blockers on
vasoconstriction under normoxic conditions
In light of these factors, we examined a number of widely
used inhibitors of CSE, thought to be the most important
sulphide-synthesizing enzyme in the vasculature, to
determine if any of them would be suitable for studying
HPV. We used concentrations of the blockers lower than
those which have previously been used to block HPV,
but which have been shown to cause full inhibition of
purified CSE (Asimakopoulou et al. 2013). Any sulphide
synthesis blocker used to examine the role of sulphide in
HPV should ideally have been first shown to fulfil three
criteria. First, it should be selective, in the sense that it does
not block contractions caused by stimuli which are not
sulphide-dependent. Secondly, it should block sulphide
synthesis, preferably in intact cells or tissues. Thirdly, it
should demonstrate the ability to inhibit some change in
tissue function that can reasonably be assumed to depend
on sulphide synthesis.
Cysteine has frequently been used to stimulate sulphide
synthesis in tissue homogenates, cells and intact tissues
(e.g. Asimakopoulou et al. 2013), and has also been shown
to enhance HPV, an effect ascribed to its ability to act
as a sulphide precursor (Olson et al. 2010). It seemed
reasonable that because sulphide causes contraction of
PAs under normoxic conditions (Olson et al. 2006),
cysteine might have the same effect. In accordance with
this concept, cysteine caused a concentration-dependent
increase in tension when applied to IPAs during an
ongoing PGF2α-induced NPV, and moreover, if applied
before PGF2α, increased the NPV when this drug was sub-
sequently applied.
Each of the CSE inhibitors we tested prevented this
potentiating effect of cysteine on the PGF2α-induced
contraction, supporting the possibility that they were
inhibiting cysteine-supported sulphide synthesis in intact
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Figure 3. Block of cysteine-dependent sulphide synthesis by rat liver by L-PAG
Sulphide production and release into PSS by pieces of rat liver (175 mg) immersed in 1 ml of PSS containing 1 mM
cysteine was recorded using an amperometric sulphide sensor. Vials were sealed to prevent the loss of sulphide,
and the solution was pre-gassed with N2/CO2 to remove O2 and thereby minimize sulphide oxidation. A, example
of sulphide release in the presence of 1 mM cysteine in the absence (left) and presence (right) of 1 mM L-PAG.
B, average cysteine-induced sulphide release in the absence and presence of L-PAG. Experiments were carried
out in paired tissues, and results are normalized to the sulphide release observed in the control tissue (n = 10,
mean ± SEM). ∗P < 0.05 vs. control.
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PAs. These results echo those of Elsey et al. (2010), who
found that 1 mM cysteine mimicked exogenously applied
sulphide in reducing ischaemia-reperfusion injury in iso-
lated rat hearts, and that this effect was blocked by 1 mM
PAG. L-PAGalso strongly blocked sulphide release induced
by 1 mM L-cysteine in pieces of liver, a tissue in which CSE
is thought to be themost important sulphide-synthesizing
enzyme (Wang, 2012).
AOAA, HA and BCA demonstrated very marked
non-selective effects on the NPV caused by PGF2α and/or
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Figure 4. Effects of cysteine on HPV evoked by gassing with 0% O2 in the absence and presence of PAG
HPV to 0% O2 before (open circles) and after (filled circles) 30 min incubation of IPAs with L-cysteine under control
conditions (B, 1 mM, n = 21) and in the presence of D,L-PAG (C, 1 mM, n = 9); or L-PAG (D, 1 mM, n = 8); and a
time control without L-cysteine (A, n = 14). In each panel, averaged data are on the left and a tension trace from
an experiment using that protocol is shown to the right. ∗P < 0.05 vs. control; #P < 0.05 vs. the effect of L-cysteine
shown in A. The amplitudes of HPV evoked by 0% O2 shown in the traces were typical of those observed under
these conditions; for all experiments the increase in tension observed after 45 min during the control HPV was
0.63 ± 0.06 mN (n = 122).
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the drug LY83583. Although LY83583 was originally
introduced as a blocker of soluble guanylate cyclase, there
is evidence that its contractile effect in PA is due to its
ability to raise cellular ROS (Knock et al. 2009), consistent
with it acting as a substrate for cellular oxoreductases
(Hasegawa et al. 2004). The profound inhibition of the
LY83583 contraction by HA and AOAA suggested that
these drugsmight be acting as anti-oxidants, in which case
they might affect HPV, which is likely to be triggered by
changes in the cellular redox state (Waypa et al. 2010),
independently of any effect on sulphide synthesis. In
contrast, the racemic mixture of PAG had no effects of
its own on contraction and L-PAG caused only a small
potentiation of contraction, which tended to wane with
time, suggesting that they might be useful agents for
probing the role of sulphide in HPV.
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Effects of cysteine and PAG on HPV
Similarly to its effect of the PGF2α-induced NPV, 1 mM
cysteine increased the amplitude of HPV by 50%. The
enhancement of HPV by cysteine was not mimicked by
either reduced or oxidized glutathione (and in fact the
latter inhibitedHPV), suggesting that the effect of cysteine
was not due to a rise in the intracellular glutathione
concentration. The lack of effect of GSH on HPV also
provides evidence that the effect of cysteine was not due
to its potential effect as a scavenger of HNO (Pino et al.
1994), as GSH shares this property (Fukuto et al. 2013).
The potentiation of HPV by cysteine was abolished
by both D,L- and L-PAG, consistent with the idea
that it was due to sulphide synthesis by CSE, and
with previous observations (Olson et al. 2010). Both
L-PAG and the racemic mixture had equivalent effects,
implying that 0.5 mM L-PAG may have been sufficient
to block CSE if D-PAG is not active against CSE
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Figure 7. Effects of D,L-PAG or L-PAG on HPV evoked by 0% O2 in normal PSS, or by 2% O2 in PSS
containing 10 μM L-cysteine, 50 μM L-cystine, and 100 μM L-glutamic acid
HPV to 0% O2 in the presence of amino acids (10 μM cysteine, 50 μM cystine and 100 μM glutamate) before
(open circles) and after (filled circles) incubation of IPAs with D,L-PAG (A, 1 mM, n = 8) or L-PAG (B, 1 mM, n = 8).
Two successive HPVs to 2% O2 under control conditions in the presence of amino acids (C, n = 12). HPV to 2%
O2 in the presence of amino acids before (open circles) and after (filled circles) 30 min incubation of IPAs with
D,L-PAG (D, 1 mM, n = 8) or L-PAG (E, 1 mM, n = 7). F, representative tension trace from a time control experiment
(left), an experiment with D,L-PAG (centre) and an experiment with L-PAG (right); in each case HPV was evoked by
hypoxic challenge with 2% O2 in PSS containing cysteine, cysteine and glutamate. The amplitudes of HPV evoked
by 2% O2 in the presence of PSS supplemented with amino acids shown in C–F were typical of those observed
under these conditions; for time control experiments the increase in tension observed after 20 min of hypoxia was
0.77 ± 0.05 mN (n = 32).
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(Asimakopoulou et al. 2013). Importantly, however, PAG
only blocked the additional increment in HPV caused
by the high concentration of cysteine, implying that the
underlying response to hypoxia was insensitive to CSE
blockade.
The lack of effect of PAG on HPV per se implied by
this observation was confirmed by examining the effect
of PAG on HPV evoked in normal PSS during hypoxic
challenge with both 0% and 2% O2. The rationale for
using both levels of hypoxia was based on the observation
that sulphide may trigger hypoxic constriction of trout
gill by increasing the mitochondrial production of ROS
(Skovgaard &Olson, 2012). In this case it seemed possible
that sulphide-induced production of ROS, and therefore
any contribution of sulphide to HPV, might be greater
when hypoxia was imposed using 2% as compared to
0% O2, as more O2 would be available to produce ROS.
Regardless of whether 0%or 2%O2 was used for the hypo-
xic challenge, PAG had no effect on HPV evoked at either
degree of hypoxia.
It is possible that lengthy incubation of PA in PSS could
deplete cells of cysteine, leaving them unable to synthesize
sufficient sulphide to affect O2 sensing. Although it might
be argued that in this case the persistence of HPV
would itself rule out a pivotal role for sulphide in O2
sensing, it is also possible that a sulphide-dependent
mechanism might contribute one of several components
of O2 sensing, and that HPV normally observed in
vitro would lack this component when cysteine becomes
depleted. We therefore incubated arteries in a cocktail
of quasi-physiological concentrations of cysteine, cystine
and glutamate (Brigham et al. 1960; Milakofsky et al.
1985; Watford, 2002; Iciek et al. 2004). The latter two
amino acids were added in addition to cysteine to allow
cells to synthesize cysteine from cystine taken up by
glutamateout/cystinein exchange via the XC− transporter
(Siow et al. 1998; Go & Jones, 2011). However, HPV was
still unaffected by PAG under these conditions, arguing
against the possibility that the lack of effect of PAG on
HPV in control PSS arises due to the lack of sufficient
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sulphide synthesis
HPV to 0% O2 before (open circles) and after (filled circles) incubation of IPAs with L-cysteine and α-ketoglutarate
(A, both 1 mM, n = 24) and in the additional presence of aspartate (B, 1 mM, n = 18). HPV to 0% O2 in the
presence of aspartate before (open circles) and after (filled circles) incubation of IPAs with L-cysteine (C, both 1 mM,
n = 11). HPV to 0% O2 in the presence of D,L-PAG before (open circles) and after (filled circles) incubation of
IPAs with L-cysteine and α-ketoglutarate (both 1 mM, n = 10). For panels A, B and D : ∗significant (P < 0.05)
effect of cysteine and α-ketoglutarate; #the response to L-cysteine and α-ketoglutarate was significantly inhibited
(P < 0.05) at all the time points during hypoxia compared to the response in A. For panel C: ∗significant (P < 0.05)
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intracellular cysteine to support sulphide synthesis and a
consequent enhancement of HPV.
It seemed unlikely that CBS would contribute to
sulphide synthesis in rat PAs, as we detected no mRNA
for this enzyme in these arteries and (Olson et al. 2010)
did not detect CBS protein in PASMCs from bovine
PAs (although it was present in the endothelium). Also,
homocysteine, which is metabolized to cysteine via CBS
(Wang, 2012), did not enhance either HPV or the PGF2α
contraction (data not shown), implying that any CBS
present would be insufficient to generate enough sulphide
to affect tension development.
A B
C
0
50
100
150
200
0
50
100
150
200
0
50
100
150
200
5 min
5 min 5 min
Amino acidscontrol
α-ketoglutarate (1 mM)
control
aspartate (1 mM)
Amino acids + α-ketoglutarate (1 mM)
N
o
rm
a
liz
e
d
 H
P
V
 a
m
p
lit
u
d
e
N
o
rm
a
liz
e
d
 H
P
V
 a
m
p
lit
u
d
e
N
o
rm
a
liz
e
d
 H
P
V
 a
m
p
lit
u
d
e
−75
−50
−25
0
25
50
75
(n = 6)
PGF 30 μM
LY 10 μM
(n = 5)%
 o
ve
r 
co
nt
ro
l
D
Figure 9. Effects of α-ketoglutarate and aspartate on HPV
A, HPV to 0% O2 in control PSS before (open circles) and after (filled circles) incubation of IPAs in α-ketoglutarate
(A, 1 mM, n = 6). B, HPV in the presence of amino acids (10 μM cysteine, 50 μM cystine and 100 μM glutamate)
before (open circles) and after (filled circles) incubation of IPAs with α-ketoglutarate (1 mM, n = 6). C, HPV in
control PSS before (open circles) and after (filled circles) incubation of IPA with aspartate (C, 1 mM, n = 8). D,
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asparate added when the contraction evoked by 10 μM LY83583 had stabilized (n = 5). No significant effect of
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Effects on HPV of co-application of cysteine and
α-ketoglutarate on HPV
The CAT/MST pathway provides an alternative route
for sulphide synthesis, the involvement of which we
also evaluated in light of our observation that MST is
expressed in rat IPAs and also was found in bovine
PAs (Olson et al. 2010) and rat. The combination of
cysteine andα-ketoglutarate enhancedHPV, and this effect
appeared to be slightly larger than that caused by cysteine
alone. Although this difference was not statistically
significant, we found that the CAT antagonist aspartate,
although it did not affect the cysteine-induced increase
in HPV, strongly attenuated the effect of cysteine +
α-ketoglutarate on HPV. PAG also partially blocked the
increase in HPV caused by cysteine and α-ketoglutarate,
implying that both CSE and CAT/MST were contributing
to sulphide synthesis under these conditions.
The increase in HPV elicited by the combination of
cysteine and α-ketoglutarate was not significantly larger
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Figure 11. mRNA expression of CγL, CβS and MST by RT-PCR
on rat IPA, aorta and brain
The expected product sizes are 427 bp and 469 bp for cystathionine
β-synthase (two alternative splice variants) (top), 160 pb for
cystathionine γ -lyase (middle) and 243 bp for MST. An extra band at
200 bp with MST is likely to be the product of an alternative splice
variant.
than that caused by cysteine alone, implying that the
CAT/MST pathway was not providing any additional
increment in [sulphide] that would promote HPV over
and above that due to the metabolism of cysteine by CSE.
Nevertheless, aspartate attenuated the effect of cysteine +
α-ketoglutarate on HPV. We speculate that a possible
explanation for these apparently inconsistent results may
be that the concentration of cysteine in cells is likely to
be below its KM values for both CAT and CSE, even if
the solution has been supplemented with 1 mM cysteine
(Singh & Banerjee, 2011). In this case, because elevating
the α-ketoglutarate concentration in PASMCs should by
the law of mass action increase the utilization of the
relatively limited pool of cellular cysteine by CAT, the
availability of cysteine for metabolism by CSE would be
reduced. Thus, adding α-ketoglutarate could activate an
aspartate-sensitive component of sulphide synthesis but at
the same time diminish PAG-sensitive sulphide synthesis,
such that overall sulphide synthesis might not change
significantly.
Crucially, application of α-ketoglutarate on its own
did not enhance HPV, either in normal PSS or in
PSS supplemented with physiological concentrations of
cysteine, cystine and glutamate. This implies that the
CAT/MST pathway is not operative unless an artificially
high concentration of cysteine is present. Likewise,
aspartate itself had no effect on HPV under control
conditions. These observations are consistent with the
properties of CAT, which is thought to function mainly
as an aspartate aminotransferase as its KM for cysteine
(22 mM) is much higher than that for asparate (1.6 mM),
whereas the intracellular concentration of aspartate
(e.g. 730 μM in mouse liver) is higher than that of
cysteine (130 μM) (Akagi, 1982; Singh & Banerjee,
2011).
HPV and thiosulphate
Olson et al. (2013) have recently suggested that
mitochondrial thiosulphate provides a reservoir of
sulphide which is mobilized during HPV by a reducing
shift in the mitochondrial redox state, with evidence for
the latter provided by Waypa et al. (2010). This proposal
was supported by the observation that HPV in bovine PAs
was increased by incubation of tissues with the reducing
agent DTT at concentrations of 100μM and above, and by
evidence that DTT increased the production of sulphide
induced by thiosulphate in homogenates of several tissues,
including liver (Olson et al. 2013). These experiments
were conducted under anoxic conditions in sealed vials
to avoid sulphide oxidation and loss to the atmosphere.
We conducted similar experiments, using pieces of intact
liver, and recorded the release of sulphide into the solution
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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over 30 min in control PSS and also in PSS supplemented
with 1 mM cysteine to promote the formation of sulphane
sulphur, which would be predicted to give rise to sulphide
when acted on by a reducing agent. Sulphide production
was small and variable in control PSS, but was substantial
in the presence of cysteine. In neither case was the release
of sulphide into the solution increased in the presence
of 3 mM DTT. Moreover, rather than increasing HPV as
described for bovine PAs, 1mMDTT virtually abolished it,
a finding consistent with reports from many laboratories
that antioxidants tend to attenuate HPV (e.g. Connolly
et al. 2013).
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Figure 12. Pathways and inhibitors of sulphide synthesis relevant to the study
Sulphide is synthesized enzymatically from cysteine by cystathione γ -lyase (CSE) and cystathionine β-synthase
(CBS); both are expressed in vascular cells but the former is thought to be more important. CSE is blocked by PAG,
BCA, AOA and HA; the latter three drugs also block CBS. Sulphide can also be produced from 3 mercaptopyruvate
(3-MP) by the mitochondrial enzyme 3 mercaptopyruvate sulphurtransferase (MST), a process which involves the
addition of sulphane sulphur to MST to form MST-SS, and its subsequent release by reductancts to yield sulphide.
3-MP is synthesized by cysteine aminotransferase (CAT) from cysteine and α-ketoglutatarate. CAT also produces
oxaloacetate from aspartate and α-ketoglutatarate, such that aspartate competitively inhibits the production of
3-MP by CAT; the affinity of CAT for aspartate is much higher than that for cysteine (Singh & Banarjee, 2011).
Cysteine can enter cells via various pathways, either as cystine through an exchange with glutamate mediated
by the Xc− transporter or directly through the alanine–serine–cysteine (ASC) or other transporters (Go & Jones,
2011). Sulphide is oxidized to thiosulphate by a mitochondrial ‘sulphide oxidation unit’ (SOU) comprising sulphide
quinone oxoreductase (SQR), a dioxygenase (ETHE1) and a sulphur transferase (Szabo et al. 2014); thiosulphate
is then oxidized further, ultimately to sulphate. Hypoxia is proposed to increase the sulphide concentration by
attenuating its mitochondrial oxidation and also by increasing the concentration of mitochondrial reductants,
which would promote the reduction of thiosulphate and the release of MST-bound sulphane sulphur (Olson et al.
2013).
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Conclusions
Although our experiments cannot rule out the possibility
that hypoxia might trigger HPV by raising the intra-
cellular [sulphide] in PASMCs via pathways we did
not investigate, the observations described here suggest
strongly that HPV occurs without the need for sulphide
synthesis by CSE or CAT/MST, and also do not support
a role for mitochondrial thiosulphate in this response.
Although it is remarkable that sulphide and hypoxia have
similar effects in a multitude of vascular preparations,
this could be explained if they cause contractions that
share a commonmechanism (e.g. increased production of
ROS via mitochondrial complex 3, as we have previously
suggested in preliminary reports; Connolly et al. 2010;
Prieto-Lloret et al. 2011; Aaronson et al. 2012). Additional
insights into the relationship between sulphide and HPV
are likely to emerge as the mechanisms by which sulphide
causes contraction in PAs are better defined.
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